Active Surveillance Versus Radical Prostatectomy in Favorable-risk Localized Prostate Cancer

Autor: Thomsen, Frederik B., Røder, M. Andreas, Jakobsen, Henrik, Langkilde, Niels Christian, Borre, Michael, Jakobsen, Erik B., Frey, Anders, Lund, Lars, Lunden, Dagmar, Dahl, Claus, Brasso, Klaus

Publikováno v: In Clinical Genitourinary Cancer August 2019 17(4):e814-e821

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

MRI target delineation may reduce long-term toxicity after prostate radiotherapy.

Autor: Sander, Lotte¹, Langkilde, Niels Christian¹, Holmberg, Mats², Carl, Jesper³

Publikováno v: Acta Oncologica. Jun2014, Vol. 53 Issue 6, p809-814. 6p. 1 Diagram, 4 Charts.

Detection Rates of 68Ga-PSMA PET/CT in Patients with Biochemical Relapse from Prostate Cancer after Radical Prostatectomy and PSA Values < 1 ng/ml:Preliminary Results from a Prospective, Multicenter Trial

Autor: Nielsen, Julie Bødker, Zacho, Helle D, Dettmann, Katja, Langkilde, Niels-Christian, Jensen, J. B., Haberkorn, Uwe, Petersen, Lars J

Publikováno v: Nielsen, J B, Zacho, H D, Dettmann, K, Langkilde, N-C, Jensen, J B, Haberkorn, U & Petersen, L J 2016, ' Detection Rates of 68 Ga-PSMA PET/CT in Patients with Biochemical Relapse from Prostate Cancer after Radical Prostatectomy and PSA Values < 1 ng/ml : Preliminary Results from a Prospective, Multicenter Trial ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 43, no. Suppl. 1, OP108, pp. S35 . < http://link.springer.com/journal/259/43/1/suppl/page/1 >

PURPOSE: The aim of this study was to assess observer agreement on the evaluation of treatment responses of bone metastases by bone scintigraphy (BS) using different scoring methods in prostate cancer patients.PATIENTS AND METHODS: Sixty-three paired

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::2b6281cde4d6e54a4112fee8241e38cc
https://vbn.aau.dk/da/publications/f2325359-f41c-44a7-8141-9af587443b07

Enzalutamid til behandling af patienter med præ-kemo metastaserende kastrationsresistent prostatacancer:Resultater af fase 3 studiet 'PREVAIL'

Autor: Iversen, Peter, Borre, Michael, Holm-Nielsen, Anders, Langkilde, Niels-Christian, Ostri, Poul, Rathenborg, Per

Publikováno v: Iversen, P, Borre, M, Holm-Nielsen, A, Langkilde, N-C, Ostri, P & Rathenborg, P 2014, ' Enzalutamid til behandling af patienter med præ-kemo metastaserende kastrationsresistent prostatacancer : Resultater af fase 3 studiet "PREVAIL" ', Dansk Urologisk Selskabs Forårsmøde 2014, Danmark, 23/03/2014 .

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5f71bb6a17a73d8e793b8d3b3d71a251
https://vbn.aau.dk/da/publications/aee7223e-e5af-4ccb-9bcb-06eb6403f460